Millennium Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,658
Closed -$135K 6060
2025
Q1
$135K Buy
+10,658
New +$144K ﹤0.01% 5384
2024
Q4
Sell
-13,560
Closed -$204K 6164
2024
Q3
$204K Sell
13,560
-4,637
-25% -$70.2K ﹤0.01% 5438
2024
Q2
$258K Hold
18,197
﹤0.01% 5004
2024
Q1
$248K Sell
18,197
-15,951
-47% -$221K ﹤0.01% 5254
2023
Q4
$460K Buy
34,148
+4,921
+17% +$60.5K ﹤0.01% 4693
2023
Q3
$364K Buy
29,227
+18,398
+170% +$242K ﹤0.01% 4829
2023
Q2
$147K Buy
+10,829
New +$149K ﹤0.01% 5232
2023
Q1
Sell
-49,394
Closed -$702K 6568
2022
Q4
$702K Buy
49,394
+14,176
+40% +$205K ﹤0.01% 4478
2022
Q3
$481K Buy
+35,218
New +$526K ﹤0.01% 5008
2020
Q1
Sell
-18,419
Closed -$321K 4125
2019
Q4
$321K Buy
18,419
+3,894
+27% +$63.9K ﹤0.01% 3630
2019
Q3
$219K Buy
+14,525
New +$233K ﹤0.01% 3740
2019
Q2
Sell
-16,487
Closed -$282K 4211
2019
Q1
$282K Buy
16,487
+852
+5% +$14.7K ﹤0.01% 3577
2018
Q4
$236K Buy
+15,635
New +$275K ﹤0.01% 3333
2018
Q3
Sell
-11,127
Closed -$209K 4059
2018
Q2
$209K Buy
+11,127
New +$209K ﹤0.01% 3544

Other funds holding HQL

Millennium Management's HQL Position: Q2 2025 in Review

Millennium Management sold out of abrdn Life Sciences Investors (HQL) in Q2 2025, closing a stake of 10,658 shares — an estimated $135K sold.

Millennium Management first reported a position in HQL in Q2 2018 and held it in 14 quarters. The position peaked at $702K in Q4 2022. 75 funds tracked by Wall St. Rank hold HQL as of Q2 2025.

  • Millennium Management reported no remaining abrdn Life Sciences Investors position as of Q2 2025 after selling out during the quarter.
  • Millennium Management sold 10,658 abrdn Life Sciences Investors shares in Q2 2025, an estimated $135K.
  • Millennium Management first reported a position in abrdn Life Sciences Investors in Q2 2018 and held it in 14 quarters.
  • Millennium Management's abrdn Life Sciences Investors position peaked at $702K in Q4 2022.
  • 75 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.